Information  X 
Enter a valid email address

PCM Global Funds ICA (IRSH)

  Print      Mail a friend

Wednesday 17 July, 2019

PCM Global Funds ICA

Appointment of Management Company

RNS Number : 8236F
PCM Global Funds ICAV
17 July 2019
 

STOCK EXCHANGE ANNOUNCEMENT

 

For Immediate Release                                                                 17 July, 2019

 

PCM Global Funds ICAV

(the "ICAV")

 

Re: Appointment of Management Company

 

The Directors of the ICAV wish to announce the appointment of Carne Global Fund Managers (Ireland) Limited (the "Manager") as the UCITS Management Company to the ICAV, effective on or about 9 July 2019.

The Manager, having its registered office at 2nd Floor, Block E, Iveagh Court, Harcourt Road, Dublin 2, was incorporated in Ireland on 10 November 2003. The Manager is a company limited by shares and is authorised and regulated as a UCITS management company by the Central Bank of Ireland under the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (as amended).

The appointment of the Manager is reflected in the revised prospectus of the ICAV and in the supplement for the Sub-Fund, the Polaris Global Value UCITS Fund. Copies of the revised prospectus and supplement are available on the website https://www.pcmglobalfundsicav.com/ and may be obtained on request, free of charge, at the registered office of the ICAV or at the offices of the Administrator

There will be no change in the investment objective, policies, restrictions or other features of the ICAV as a result of this appointment.

 

 

 Enquiries to:

 

Davy

Paul Boland

+353 1 614 3378

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISESFDSAWFUSEDW

a d v e r t i s e m e n t